2024-2029 Global Therapeutic Drug Monitoring Market Assessment for 28 Assays in US, Europe, Japan-2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

This unique report from the Publisher provides information and analysis, including:

• Supplier Sales and Shares by Segment and Test
• Volume and Sales Segment Forecasts by Test
• Supplier Strategies and SWOT Analysis
• Instrumentation Pipeline
• Emerging Technologies
• Opportunities for New Analyzers and Consumables
• Market Challenges and Risks

The report provides test volume and sales forecasts by country and market segment for the following assays:

CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, Vitamin D

The report is available by country, section, and can be customized to specific information needs and budget.

Country Analyses

France, Germany, Italy, Japan, Spain, UK, US

Rationale

During the next decade, the anemia diagnostics market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifyingpetition. Some segments will start resemblingmodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.